Antileishmanial metallodrugs and the elucidation of new drug targets linked to post-translational modifications machinery: pitfalls and progress

Despite the increasing number of manuscripts describing potential alternative antileishmanial compounds, little is advancing on translating these knowledges to new products to treat leishmaniasis. This is in part due to the lack of standardisations during pre-clinical drug discovery stage and also d...

Descripción completa

Detalles Bibliográficos
Autores principales: do Monte, Rubens Lima, Moreira, Paulo Otávio Lourenço, de Sousa, Alessandra Mara, Garcia, Miguel Antonio do Nascimento, Maran, Suellen Rodrigues, Moretti, Nilmar Silvio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Oswaldo Cruz, Ministério da Saúde 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944189/
https://www.ncbi.nlm.nih.gov/pubmed/35320824
http://dx.doi.org/10.1590/0074-02760220403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944189/
https://www.ncbi.nlm.nih.gov/pubmed/35320824
http://dx.doi.org/10.1590/0074-02760220403

Ejemplares similares